First & New UVVisible Spectroscopic Method Development of Rilpivirine,Used

First & New UVVisible Spectroscopic Method Development of Rilpivirine,Used

In Stock
SKU: DADAX3659363081
Brand: LAP Lambert Academic Publishing
$68.25 $97.50
Save $29.25
Quantity
Add to wishlist
Add to compare

Processing time: 1-3 days

US Orders Ships in: 3-5 days

International Orders Ships in: 8-12 days

Return Policy: 15-days return on defective items

Payment Option
Payment Methods

Help

If you have any questions, you are always welcome to contact us. We'll get back to you as soon as possible, withing 24 hours on weekdays.

Customer service

All questions about your order, return and delivery must be sent to our customer service team by e-mail at yourstore@yourdomain.com

Sale & Press

If you are interested in selling our products, need more information about our brand or wish to make a collaboration, please contact us at press@yourdomain.com

Analytical method development of different doses form & API of any Drug molecule is a challenging task for a scientist nowadays. If the molecule is brand new, it adds up even more difficulties. Rilpivirine is a new antiretro viral drug used to treat HIV infected patients. Recently this drug has received USFDA approval, but as of now no single method is available to determine the drug by using UVVisible Spectrophotometer. This book is aiming to address that gap with vivid methodology, proper explanation & description. An effort has been made to focus on the way of doing method development & its validation according to official agencies in maximum parameters along with all UVSpectrums, Figures & Tables. Written in a lucid manner, this book is a must have for students those who are pursuing Master or Bachelor degree in Pharmacy or analytical chemistry or any other related courses. Researchers in this field and even company personnel analyzing this drug will find this book helpful.

⚠️ WARNING (California Proposition 65):

This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.

For more information, please visit www.P65Warnings.ca.gov.

Recently Viewed